KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Medpace Holdings (MEDP) Return on Sales (2016 - 2025)

Medpace Holdings' Return on Sales history spans 11 years, with the latest figure at 0.19% for Q4 2025.

  • For Q4 2025, Return on Sales fell 3.0% year-over-year to 0.19%; the TTM value through Dec 2025 reached 0.18%, down 1.0%, while the annual FY2025 figure was 0.18%, 1.0% down from the prior year.
  • Return on Sales reached 0.19% in Q4 2025 per MEDP's latest filing, up from 0.17% in the prior quarter.
  • In the past five years, Return on Sales ranged from a high of 0.22% in Q4 2024 to a low of 0.13% in Q2 2023.
  • Average Return on Sales over 5 years is 0.17%, with a median of 0.17% recorded in 2023.
  • Peak YoY movement for Return on Sales: dropped -3bps in 2021, then grew 6bps in 2024.
  • A 5-year view of Return on Sales shows it stood at 0.16% in 2021, then grew by 7bps to 0.17% in 2022, then decreased by -10bps to 0.16% in 2023, then surged by 39bps to 0.22% in 2024, then dropped by -13bps to 0.19% in 2025.
  • Per Business Quant, the three most recent readings for MEDP's Return on Sales are 0.19% (Q4 2025), 0.17% (Q3 2025), and 0.15% (Q2 2025).